ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 717859 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 717859; 2) Community: the network communities that were significantly associated with the response to NSC 717859; 3) Molecule: the relationships between components within communities and NSC 717859; 4) MDR: the compounds that were significantly associated with the NSC 717859.

NSC Compound Enrichment Correlation
NSC 111533 Methoxycamptothecin 0.0273093708703115 -0.067440496
NSC 244714 Benzoic acid, 3,5-dinitro-2-(1H-purin-6-ylthio)-, ethyl ester 0.0273093708703115 0.020648252
NSC 2785 Null 0.0273093708703115 0.26223756
NSC 305780 Ethanol, compd. with 6-(2-naphthalenylthio)-2,4-quinazolinediamine (1:2) 0.0273093708703115 -0.083597743
NSC 3088 Chlorambucil 0.0273093708703115 -0.0063098475
NSC 327182 L-Glutamic acid, N-[4-[[(2-amino-1,4-dihydro-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]benzoyl]- 0.0273093708703115 -0.0052566844
NSC 344505 5H-[1,3]Dioxolo[5,6]indeno[1,2-c]isoquinoline- 5,12(6H)-dione, 6a,12a-dihydro-2,3-dimethoxy- 6-methyl-, cis- 0.0273093708703115 0.038802197
NSC 351907 MASTOPARAN 0.0273093708703115 -0.12681402
NSC 356885 Leucinostatin A (9CI) 0.0273093708703115 -0.13219181
NSC 378734 From Cephalodiscus gilchristi 0.0273093708703115 -0.02019966
Total:57  Current:33    [First] [Prev] [Next] [Last]